Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.
Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Arch Pharm (Weinheim). 2024 Aug;357(8):e2300676. doi: 10.1002/ardp.202300676. Epub 2024 Apr 29.
Coenzyme Q (CoQ) is an essential, lipid-soluble vitamin involved in electron transport in the oxidoreductive reactions of the mitochondrial respiratory chain. Structurally, the quinone ring is connected to an isoprenoid moiety, which has a high molecular weight. Over the years, coenzyme Q has become relevant in the treatment of several diseases, like neurodegenerative disorders, coronary diseases, diabetes, hypercholesterolemia, cancer, and others. According to studies, CoQ supplementation might be beneficial in the treatment of CoQ deficiencies and disorders associated with oxidative stress. However, the water-insoluble nature of CoQ is a major hindrance to successful supplementation. So far, many advancements in CoQ bioavailability enhancement have been developed using novel drug carriers such as solid dispersion, liposomes, micelles, nanoparticles, nanoemulsions, self-emulsifying drug systems, or various innovative approaches (CoQ complexation with proteins). This article aims to provide an update on methods to improve CoQ solubility and bioavailability.
辅酶 Q(CoQ)是一种必需的脂溶性维生素,参与线粒体呼吸链的氧化还原反应中的电子传递。从结构上看,醌环与一个具有高分子量的异戊二烯部分相连。多年来,辅酶 Q 在治疗多种疾病方面变得相关,如神经退行性疾病、冠心病、糖尿病、高胆固醇血症、癌症等。根据研究,辅酶 Q 补充可能有益于治疗辅酶 Q 缺乏症和与氧化应激相关的疾病。然而,辅酶 Q 的不溶于水的性质是成功补充的主要障碍。到目前为止,已经使用新型药物载体(如固体分散体、脂质体、胶束、纳米粒子、纳米乳液、自乳化药物系统或各种创新方法(与蛋白质的辅酶 Q 络合))开发了许多提高辅酶 Q 生物利用度的方法。本文旨在提供一种关于提高辅酶 Q 溶解度和生物利用度的方法的最新信息。